Archive for inflammatory disease

Syntrix Reports the Cellular Mechanism of Compounds It Discovered to Treat COPD and Lung Disease in Neonates

Congratulations to Syntrix scientists and their collaborators at Montana State University on their latest publication in The Journal of Pharmacology and Experimental Therapeutics. Signficance: These studies demonstrate that compounds discovered by Syntrix to treat COPD and lung disease in neonates work by inhibiting CXCR1/2, G-protein coupled receptors, via a novel intracellular mechanism. Abstract: The chemokine receptors CXCR1/2 are […]